Caveats in reporting of national vaccine uptake
J Glob Health
.
2024 Feb 9:14:03006.
doi: 10.7189/jogh.14.03006.
Authors
Tristan Millington
1
,
Kirsty Morrison
2
,
Karen Jeffrey
1
,
Christopher Sullivan
2
,
Amanj Kurdi
3
4
5
6
,
Adeniyi Francis Fagbamigbe
7
,
Ben Swallow
8
,
Ting Shi
1
,
Syed Ahmar Shah
1
,
Steven Kerr
1
,
Colin R Simpson
1
9
,
Lewis D Ritchie
7
,
Chris Robertson
2
10
,
Aziz Sheikh
1
,
Igor Rudan
1
11
Affiliations
1
Usher Institute, The University of Edinburgh, Edinburgh, UK.
2
Public Health Scotland, Glasgow, UK.
3
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom.
4
Department of Clinical Pharmacy, College of Pharmacy, Hawler Medical University, Erbil, Iraq.
5
College of Pharmacy, Al-Kitab University, Kirkuk, Iraq.
6
School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.
7
School of Medicine, Medical Sciences & Nutrition, Academic Primary Care, University of Aberdeen, UK.
8
School of Mathematics and Statistics, University of St Andrews, UK.
9
School of Health, Wellington Faculty of Health, Victoria University of Wellington, Wellington, NZ.
10
Department of Mathematics and Statistics, University of Strathclyde, Glasgow, UK.
11
Algebra University College, Zagreb, Croatia.
PMID:
38330197
PMCID:
PMC10852533
DOI:
10.7189/jogh.14.03006
No abstract available
MeSH terms
Humans
Influenza Vaccines*
Influenza, Human* / prevention & control
Substances
Influenza Vaccines